Prognosis of Paradoxical Low-flow Low-gradient Aortic Stenosis After Transcatheter Aortic Valve Replacement
Overview
Affiliations
Aims: In paradoxical low-flow low-gradient severe aortic stenosis (PLFLG AS) patients, stroke volume index (SVI) is reduced despite preserved left ventricular ejection fraction (LVEF). Although reduced SVI is already known as a poor prognostic predictor, the outcomes of PLFLG AS patients after transcatheter aortic valve replacement (TAVR) have not been clearly defined. We retrospectively investigated the post-TAVR outcomes of PLFLG AS patients in comparison with normal-flow high-gradient aortic stenosis (NFHG AS) patients.
Methods: The current observational study included 245 patients with NFHG AS (mean transaortic pressure gradient ≥40 mmHg and LVEF ≥ 50%) and 48 patients with PLFLG AS (mean transaortic pressure gradient <40 mmHg, LVEF ≥ 50% and SVI < 35 ml/m2). The endpoints were all-cause mortality, hospitalization for valve-related symptoms or worsening congestive heart failure and New York Heart Association functional class III or IV.
Results: PLFLG AS patients had a significantly higher proportion with a history of atrial fibrillation/flutter as compared with NFHG AS patients. All-cause mortality of PLFLG AS patients was worse than that of NFHG AS patients (P = 0.047). Hospitalization for valve-related symptoms or worsening congestive heart failure was more frequent in PLFLG AS patients than in NFHG AS patients (P = 0.041). New York Heart Association functional class III-IV after TAVR was more frequently observed in PLFLG AS patients (P = 0.019).
Conclusion: The outcomes of PLFLG AS patients were worse than those of NFHG AS patients in this study. Preexisting atrial fibrillation/flutter was frequent in PLFLG AS patients, and may affect their post-TAVR outcomes. Therefore, closer post-TAVR follow-up should be considered for these patients.
Nies R, Nettersheim F, Braumann S, Ney S, Ochs L, Dohr J Eur J Heart Fail. 2024; 26(11):2340-2352.
PMID: 38887164 PMC: 11659504. DOI: 10.1002/ejhf.3329.
Beuthner B, Elkenani M, Evert K, Mustroph J, Jacob C, Paul N ESC Heart Fail. 2024; 11(3):1636-1646.
PMID: 38407567 PMC: 11098657. DOI: 10.1002/ehf2.14709.
Wagener M, Reuthebuch O, Heg D, Tuller D, Ferrari E, Grunenfelder J J Am Heart Assoc. 2023; 12(12):e029489.
PMID: 37301760 PMC: 10356021. DOI: 10.1161/JAHA.123.029489.